Medical Design Briefs - August 2023 - 2

Patient Demand Drives Smart Drug-Delivery Systems Market
A
recent report reveals that the growth in prevalence of chronic
diseases and rise in patient preference for advanced
drug-delivery systems are driving the global smart drug-delivery
systems market. In particular, it points to products that facilitate
self-medication gaining traction as medical technology developers
attempt to make their offerings more patient-centric.
The report, " Smart Drug Delivery Systems Market " published
by Transparency Market Research, forecasts the market to
" flourish " at a CAGR of 15.2 percent from 2022 to 2031, increasing
to a value of $36 billion. As of 2023, a valuation of $9.2 billion
is projected for the smart drug-delivery systems market.
" Drug formulators focusing on therapeutic areas need to pay
close attention to patient experience in order to optimize adherence, "
the report says. " Reduced dosage frequency and improved
ease of administration are critical to providing the best
possible experience for patients and encouraging adherence to
their treatment regimen. "
According to the report, patient preference is shifting toward
controlled drug-delivery systems, as the healthcare sector's digitalization
accelerates through the gradual integration of diagnostic
point-of-care sensors and connected computation platforms into
patients' daily routines. Metered dose inhalers, nebulizers, and
dry powder inhalers are used for pulmonary drug delivery.
The analysts note that market players are developing products
that help ensure that drugs achieve the desired therapeutic levels
while avoiding the need for frequent administration. This
enables patients to adhere to their drug regimens and thus improve
compliance. For example, in March 2022, Novo Nordisk
A/S launched the NovoPen 6 and NovoPen Echo Plus smart connected
insulin pens available by prescription in the United Kingdom
for people with diabetes who use Novo Nordisk insulin.
The connected wearable injectors segment held the largest
share of the market in 2021 and is expected to maintain its dominance.
" Growth of the segment can be ascribed to the rise in
concerns over needle stick injuries, surge in geriatric population
and prevalence of chronic diseases, and increase in demand
for continuous health monitoring.
The connected autoinjectors segment is likely to grow significantly
during the forecast period. Market players are launching
new connected autoinjectors that improve patient experience.
Sherrie Trigg
Editor and Director of Medical Content
A copy of the report is available at https://tinyurl.com/
smart-drug-delivery.
Read the white paper " Emerging Trends in
Drug Delivery, " from CAS, a division of the
American Chemical Society.
Medical-grade tubing - Over 250 tubing options available
In stock and ready for immediate delivery!
* Conveniently packaged small coils for prototyping
* Extended lengths for large-scale production requirements
* Cut-to-length pieces and custom coil sizes
* Low minimum order quantities
* Free samples
Log on to qosina.com to learn more about our tubing options,
request samples or place an order.
Qosina Corp.:
Qosina Europe:
qosina.com
+1 631 242-3000
qosina.com/qosina-europe
info@qosina.com
+39 02 66401337
info@qosinaeurope.com
2
www.medicaldesignbriefs.com
Medical Design Briefs, July 2023
https://tinyurl.com/smart-drug-delivery https://tinyurl.com/smart-drug-delivery http://info.hotims.com/84482-806 http://www.medicaldesignbriefs.com
Medical Design Briefs - August 2023

Table of Contents for the Digital Edition of Medical Design Briefs - August 2023
